# Neurobiological and Immunological Mechanisms of Dyspnea in ALS (BIOPNEA)

> **NCT04332198** · NA · UNKNOWN · sponsor: **Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil** · enrollment: 30 (estimated)

## Conditions studied

- Shortness of Breath
- Dyspnea
- Amyotrophic Lateral Sclerosis

## Interventions

- **OTHER:** biological test

## Key facts

- **NCT ID:** NCT04332198
- **Lead sponsor:** Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-07
- **Primary completion:** 2024-10
- **Final completion:** 2024-10
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2022-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04332198

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04332198, "Neurobiological and Immunological Mechanisms of Dyspnea in ALS (BIOPNEA)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04332198. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*